Finally, using tumor methylome data of IDH-WT and IDH-MUT gliomas from the glioma Atlas [27], we found that 16 out of the 32 identified ECM related genes had significantly differential DNA methylation in gene promoters (Fig. 4D) and 11 within gene bodies (Fig. 4E). The gene discussed is IDH2; the disease is central nervous system cancer.